These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 34879385)
1. Effect of Mineralocorticoid Receptor Antagonists on the Prognosis of Patients with Ventricular Tachyarrhythmias. Schupp T; von Zworowsky M; Reiser L; Abumayyaleh M; Weidner K; Mashayekhi K; Bertsch T; Abba ML; Akin I; Behnes M Pharmacology; 2022; 107(1-2):35-45. PubMed ID: 34879385 [TBL] [Abstract][Full Text] [Related]
2. No impact of mineralocorticoid receptor antagonists on long-term recurrences of ventricular tachyarrhythmias. Schupp T; Akin I; Reiser L; Bollow A; Taton G; Borggrefe M; Reichelt T; Ellguth D; Engelke N; Barre M; Müller J; Weidner K; Kim SH; Akin M; Große Meininghaus D; Behnes M Pacing Clin Electrophysiol; 2021 Feb; 44(2):213-224. PubMed ID: 33314234 [TBL] [Abstract][Full Text] [Related]
3. The Effectiveness of Eplerenone vs Spironolactone on Left Ventricular Systolic Function, Hospitalization and Cardiovascular Death in Patients With Chronic Heart Failure-HFrEF. Naser N; Durak-Nalbantic A; Sabanovic-Bajramovic N; Karic A Med Arch; 2023 Apr; 77(2):105-111. PubMed ID: 37260796 [TBL] [Abstract][Full Text] [Related]
4. Atrial fibrillation increases the risk of recurrent ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients. Rusnak J; Behnes M; Reiser L; Schupp T; Bollow A; Reichelt T; Borggrefe M; Ellguth D; Engelke N; El-Battrawy I; Ansari U; Barre M; Weidner K; Müller J; Barth C; Meininghaus DG; Akin M; Bertsch T; Taton G; Akin I Arch Cardiovasc Dis; 2021; 114(6-7):443-454. PubMed ID: 33967015 [TBL] [Abstract][Full Text] [Related]
5. COPD increases cardiac mortality in patients presenting with ventricular tachyarrhythmias and aborted cardiac arrest. Rusnak J; Behnes M; Schupp T; Reiser L; Bollow A; Taton G; Reichelt T; Ellguth D; Engelke N; Hoppner J; Weidner K; El-Battrawy I; Mashayekhi K; Weiß C; Borggrefe M; Akin I Respir Med; 2018 Dec; 145():153-160. PubMed ID: 30509705 [TBL] [Abstract][Full Text] [Related]
6. Type 2 diabetes is independently associated with all-cause mortality secondary to ventricular tachyarrhythmias. Weidner K; Behnes M; Schupp T; Rusnak J; Reiser L; Bollow A; Taton G; Reichelt T; Ellguth D; Engelke N; Hoppner J; El-Battrawy I; Mashayekhi K; Weiß C; Borggrefe M; Akin I Cardiovasc Diabetol; 2018 Sep; 17(1):125. PubMed ID: 30200967 [TBL] [Abstract][Full Text] [Related]
7. Male sex increases mortality in ventricular tachyarrhythmias. Weidner K; Behnes M; Rusnak J; Schupp T; Hoppner J; Taton G; Reiser L; Bollow A; Reichelt T; Ellguth D; Engelke N; Kuche P; Ansari U; El-Battrawy I; Lang S; Nienaber CA; Akin M; Mashayekhi K; Ferdinand D; Weiß C; Borggrefe M; Akin I Intern Med J; 2019 Jun; 49(6):711-721. PubMed ID: 30479061 [TBL] [Abstract][Full Text] [Related]
8. Impact of chronic kidney disease on recurrent ventricular tachyarrhythmias in ICD recipients. Weidner K; Behnes M; Weiß C; Nienaber C; Reiser L; Bollow A; Taton G; Reichelt T; Ellguth D; Engelke N; Rusnak J; Schupp T; Kim SH; Barth C; Hoppner J; Akin M; Mashayekhi K; Borggrefe M; Akin I Heart Vessels; 2019 Nov; 34(11):1811-1822. PubMed ID: 31076852 [TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of chronic kidney disease and renal replacement therapy in ventricular tachyarrhythmias and aborted cardiac arrest. Weidner K; Behnes M; Schupp T; Rusnak J; Reiser L; Taton G; Reichelt T; Ellguth D; Engelke N; Bollow A; El-Battrawy I; Ansari U; Hoppner J; Nienaber CA; Mashayekhi K; Weiß C; Akin M; Borggrefe M; Akin I Clin Res Cardiol; 2019 Jun; 108(6):669-682. PubMed ID: 30578436 [TBL] [Abstract][Full Text] [Related]
10. Association Between Mineralocorticoid Receptor Antagonist Use and Outcome in Myocardial Infarction Patients With Heart Failure. Löfman I; Szummer K; Olsson H; Carrero JJ; Lund LH; Jernberg T J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 29980521 [TBL] [Abstract][Full Text] [Related]
11. Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction. Serenelli M; Jackson A; Dewan P; Jhund PS; Petrie MC; Rossignol P; Campo G; Pitt B; Zannad F; Ferreira JP; McMurray JJV JACC Heart Fail; 2020 Mar; 8(3):188-198. PubMed ID: 31926854 [TBL] [Abstract][Full Text] [Related]
12. Digitalis therapy in patients with ventricular tachyarrhythmias. Schupp T; Müller J; von Zworowsky M; Abumayyaleh M; Weidner K; Rusnak J; Mashayekhi K; Bertsch T; Akin I; Behnes M Scand Cardiovasc J; 2022 Dec; 56(1):198-207. PubMed ID: 35792713 [No Abstract] [Full Text] [Related]
13. Electrical storm is associated with impaired prognosis compared to ventricular tachyarrhythmias. Behnes M; Müller J; Ellguth D; Schupp T; Taton G; Reiser L; Engelke N; Reichelt T; Bollow A; Kim SH; Barth C; Saleh A; Rusnak J; Weidner K; Nienaber CA; Mashayekhi K; Akin M; Bertsch T; Weiß C; Borggrefe M; Akin I Int J Cardiol; 2019 Oct; 292():119-125. PubMed ID: 31076250 [TBL] [Abstract][Full Text] [Related]
14. Comparable survival in ischemic and nonischemic cardiomyopathy secondary to ventricular tachyarrhythmias and aborted cardiac arrest. Rusnak J; Behnes M; Schupp T; Weiß C; Nienaber C; Lang S; Reiser L; Bollow A; Taton G; Reichelt T; Ellguth D; Engelke N; Ansari U; El-Battrawy I; Bertsch T; Akin M; Mashayekhi K; Borggrefe M; Akin I Coron Artery Dis; 2019 Jun; 30(4):303-311. PubMed ID: 30896453 [TBL] [Abstract][Full Text] [Related]